Atyr Pharma Inc also files under LIFE; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 27, 2026 | Schimmel Paul | Director | Buy(P) | 100K | $0.50 | $50K |
| May 11, 2026 | Lucas Svetlana | Director | Grant(A) | 50K | — | $0 |
| May 11, 2026 | Schimmel Paul | Director | Grant(A) | 50K | — | $0 |
| May 11, 2026 | Coughlin Timothy | Director | Grant(A) | 50K | — | $0 |
| May 11, 2026 | Benevich Eric | Director | Grant(A) | 50K | — | $0 |
| May 11, 2026 | Zaknoen Sara | Director | Grant(A) | 50K | — | $0 |
| May 11, 2026 | Gross Jane A | Director | Grant(A) | 50K | — | $0 |
| Feb 4, 2026 | Denyes Nancy | General Counsel | Sell(S) | 1K | $0.98 | $1K |
| Feb 4, 2026 | Broadfoot Jill Marie | Chief Financial Officer | Sell(S) | 2K | $0.98 | $2K |
| Feb 4, 2026 | Shukla Sanjay | President and CEO, Director | Sell(S) | 4K | $0.98 | $4K |
| Feb 3, 2026 | Denyes Nancy | General Counsel | Option exercise(M) | 3K | — | $0 |
| Feb 3, 2026 | Broadfoot Jill Marie | Chief Financial Officer | Option exercise(M) | 4K | — | — |
| Feb 3, 2026 | Shukla Sanjay | President and CEO, Director | Option exercise(M) | 10K | — | — |
| Feb 3, 2026 | Denyes Nancy | General Counsel | Option exercise(M) | 3K | — | — |
| Feb 3, 2026 | Broadfoot Jill Marie | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Feb 3, 2026 | Shukla Sanjay | President and CEO, Director | Option exercise(M) | 10K | — | $0 |
| Jan 9, 2026 | Denyes Nancy | General Counsel | Grant(A) | 413K | — | $0 |
| Jan 9, 2026 | Broadfoot Jill Marie | Chief Financial Officer | Grant(A) | 413K | — | $0 |
| Jan 9, 2026 | Shukla Sanjay | President and CEO, Director | Grant(A) | 1.5M | — | $0 |
| Oct 9, 2025 | Schimmel Paul | Director | Buy(P) | 318K | $0.94 | $299K |
| Oct 8, 2025 | Schimmel Paul | Director | Buy(P) | 682K | $0.90 | $614K |
| May 1, 2025 | Benevich Eric | Director | Grant(A) | 50K | — | $0 |
| May 1, 2025 | Coughlin Timothy | Director | Grant(A) | 50K | — | $0 |
| May 1, 2025 | Lucas Svetlana | Director | Grant(A) | 50K | — | $0 |
| May 1, 2025 | Schimmel Paul | Director | Grant(A) | 50K | — | $0 |
| May 1, 2025 | Zaknoen Sara | Director | Grant(A) | 50K | — | $0 |
| May 1, 2025 | Gross Jane A | Director | Grant(A) | 50K | — | $0 |
| Mar 17, 2025 | Gross Jane A | Director | Buy(P) | 4K | $4.00 | $15K |
| Feb 4, 2025 | Broadfoot Jill Marie | Chief Financial Officer | Sell(S) | 1K | $3.78 | $5K |
| Feb 4, 2025 | Denyes Nancy | General Counsel | Sell(S) | 899 | $3.78 | $3K |
| Feb 3, 2025 | Shukla Sanjay | President and CEO, Director | Option exercise(M) | 10K | — | $0 |
| Feb 3, 2025 | Shukla Sanjay | President and CEO, Director | Option exercise(M) | 10K | — | — |
| Feb 3, 2025 | Broadfoot Jill Marie | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Feb 3, 2025 | Denyes Nancy | General Counsel | Option exercise(M) | 3K | — | $0 |
| Feb 3, 2025 | Broadfoot Jill Marie | Chief Financial Officer | Option exercise(M) | 4K | — | — |
| Feb 3, 2025 | Denyes Nancy | General Counsel | Option exercise(M) | 3K | — | — |
| Jan 8, 2025 | Shukla Sanjay | President and CEO, Director | Grant(A) | 1.0M | — | $0 |
| Jan 8, 2025 | Broadfoot Jill Marie | Chief Financial Officer | Grant(A) | 275K | — | $0 |
| Jan 8, 2025 | Denyes Nancy | General Counsel | Grant(A) | 275K | — | $0 |
| Dec 10, 2024 | Benevich Eric | Director | Grant(A) | 100K | — | $0 |
| Jul 24, 2024 | Schimmel Paul | Director | Buy(P) | 52K | $1.93 | $101K |
| Jul 23, 2024 | Schimmel Paul | Director | Buy(P) | 7K | $1.82 | $12K |
| Jul 22, 2024 | Schimmel Paul | Director | Buy(P) | 41K | $1.74 | $71K |
| Jun 5, 2024 | Denyes Nancy | General Counsel | Buy(P) | 5K | $1.86 | $9K |
| May 31, 2024 | Shukla Sanjay | President and CEO, Director | Buy(P) | 20K | $1.81 | $36K |
| May 31, 2024 | Broadfoot Jill Marie | Chief Financial Officer | Buy(P) | 5K | $1.79 | $9K |
| May 30, 2024 | Coughlin Timothy | Director | Buy(P) | 50K | $1.75 | $88K |
| May 22, 2024 | Lucas Svetlana | Director | Grant(A) | 24K | — | $0 |
| May 22, 2024 | Clarke John K | Director | Grant(A) | 24K | — | $0 |
| May 22, 2024 | Zaknoen Sara | Director | Grant(A) | 24K | — | $0 |
| May 22, 2024 | Gross Jane A | Director | Grant(A) | 24K | — | $0 |
| May 22, 2024 | Coughlin Timothy | Director | Grant(A) | 24K | — | $0 |
| May 22, 2024 | Schimmel Paul | Director | Grant(A) | 24K | — | $0 |
| Feb 6, 2024 | Broadfoot Jill Marie | Chief Financial Officer | Sell(S) | 2K | $1.69 | $3K |
| Feb 5, 2024 | Shukla Sanjay | President and CEO, Director | Option exercise(M) | 10K | — | $0 |
| Feb 5, 2024 | Shukla Sanjay | President and CEO, Director | Option exercise(M) | 10K | — | — |
| Feb 5, 2024 | Broadfoot Jill Marie | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Feb 5, 2024 | Broadfoot Jill Marie | Chief Financial Officer | Option exercise(M) | 4K | — | — |
| Feb 5, 2024 | Denyes Nancy | General Counsel | Option exercise(M) | 3K | — | $0 |
| Feb 5, 2024 | Denyes Nancy | General Counsel | Option exercise(M) | 3K | — | — |
| Jan 5, 2024 | Denyes Nancy | General Counsel | Grant(A) | 150K | — | $0 |
| Jan 5, 2024 | Broadfoot Jill Marie | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Jan 5, 2024 | Shukla Sanjay | President and CEO, Director | Grant(A) | 600K | — | $0 |
| Dec 12, 2023 | Shukla Sanjay | President and CEO, Director | Buy(P) | 12K | $1.18 | $14K |
| Dec 11, 2023 | Shukla Sanjay | President and CEO, Director | Buy(P) | 3K | $1.17 | $4K |
| Nov 13, 2023 | Shukla Sanjay | President and CEO, Director | Buy(P) | 14K | $1.11 | $15K |
| Nov 10, 2023 | Shukla Sanjay | President and CEO, Director | Buy(P) | 1K | $1.14 | $2K |
| Jul 28, 2023 | Shukla Sanjay | President and CEO, Director | Buy(P) | 15K | $2.01 | $30K |
| May 17, 2023 | Gross Jane A | Director | Grant(A) | 12K | — | $0 |
| May 17, 2023 | Lucas Svetlana | Director | Grant(A) | 12K | — | $0 |
| May 17, 2023 | Schimmel Paul | Director | Grant(A) | 12K | — | $0 |
| May 17, 2023 | Coughlin Timothy | Director | Grant(A) | 12K | — | $0 |
| May 17, 2023 | Coughlin Timothy | Director | Gift(G) | 6K | — | $0 |
| May 17, 2023 | Coughlin Timothy | Director | Gift(G) | 6K | — | $0 |
| May 17, 2023 | Zaknoen Sara | Director | Grant(A) | 12K | — | $0 |
| May 17, 2023 | Clarke John K | Director | Grant(A) | 12K | — | $0 |
| May 10, 2023 | Schimmel Paul | Director | Buy(P) | 200K | $2.25 | $450K |
| Apr 26, 2023 | Zaknoen Sara | Director | Option exercise(M) | 6K | — | $0 |
| Apr 26, 2023 | Zaknoen Sara | Director | Option exercise(M) | 6K | — | — |
| Apr 26, 2023 | Clarke John K | Director | Option exercise(M) | 6K | — | — |
| Apr 26, 2023 | Schimmel Paul | Director | Option exercise(M) | 6K | — | $0 |
| Apr 26, 2023 | Schimmel Paul | Director | Option exercise(M) | 6K | — | — |
| Apr 26, 2023 | Lucas Svetlana | Director | Option exercise(M) | 6K | — | $0 |
| Apr 26, 2023 | Lucas Svetlana | Director | Option exercise(M) | 6K | — | — |
| Apr 26, 2023 | Gross Jane A | Director | Option exercise(M) | 6K | — | $0 |
| Apr 26, 2023 | Gross Jane A | Director | Option exercise(M) | 6K | — | — |
| Apr 26, 2023 | Coughlin Timothy | Director | Option exercise(M) | 6K | — | $0 |
| Apr 26, 2023 | Coughlin Timothy | Director | Option exercise(M) | 6K | — | — |
| Apr 26, 2023 | Clarke John K | Director | Option exercise(M) | 6K | — | $0 |
| Feb 16, 2023 | Shukla Sanjay | President and CEO, Director | Grant(A) | 336K | — | $0 |
| Feb 16, 2023 | Broadfoot Jill Marie | Chief Financial Officer | Grant(A) | 84K | — | $0 |
| Feb 16, 2023 | Denyes Nancy | General Counsel | Grant(A) | 84K | — | $0 |
| Feb 6, 2023 | Broadfoot Jill Marie | Chief Financial Officer | Sell(S) | 2K | $2.36 | $4K |
| Feb 3, 2023 | Denyes Nancy | General Counsel | Option exercise(M) | 3K | — | — |
| Feb 3, 2023 | Denyes Nancy | General Counsel | Option exercise(M) | 3K | — | $0 |
| Feb 3, 2023 | Shukla Sanjay | President and CEO, Director | Option exercise(M) | 10K | — | $0 |
| Feb 3, 2023 | Broadfoot Jill Marie | Chief Financial Officer | Option exercise(M) | 4K | — | — |
| Feb 3, 2023 | Shukla Sanjay | President and CEO, Director | Option exercise(M) | 10K | — | — |
| Feb 3, 2023 | Broadfoot Jill Marie | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Nov 21, 2022 | Shukla Sanjay | President and CEO, Director | Buy(P) | 10K | $2.14 | $21K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Atyr Pharma Inc, SEC CIK 0001339970. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under ATYR and shows every filing by that issuer (also filed as LIFE).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for ATYR